BioCentury
ARTICLE | Company News

BioSphings AG, Shogoo deal

February 13, 2006 8:00 AM UTC

Shogoo acquired exclusive worldwide rights to develop and commercialize BioSphing's SPK-0601, which is in preclinical development to treat diseases caused by viral infection. Financial terms were not ...